Covered recipient · General Payments record
HAMIDEH S MOAYEDPARDAZI
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$7,131.51
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,518.55 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $674.61 | 22 |
| GLAUKOS CORPORATION | $413.89 | 4 |
| Alcon Laboratories Inc | $315.30 | 7 |
| Carl Zeiss Meditec USA, Inc. | $93.74 | 1 |
| Nova Eye, Inc. | $21.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048550 | CMS |
| ABBVIE INC. | $22.38 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048552 | CMS |
| ABBVIE INC. | $23.12 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048554 | CMS |
| ABBVIE INC. | $105.83 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048556 | CMS |
| ABBVIE INC. | $78.37 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048558 | CMS |
| ABBVIE INC. | $27.69 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048560 | CMS |
| ABBVIE INC. | $11.97 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048562 | CMS |
| ABBVIE INC. | $23.09 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048564 | CMS |
| ABBVIE INC. | $121.47 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048566 | CMS |
| ABBVIE INC. | $24.61 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048568 | CMS |
| ABBVIE INC. | $14.90 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048570 | CMS |
| ABBVIE INC. | $7.65 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048572 | CMS |
| ABBVIE INC. | $10.21 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048574 | CMS |
| ABBVIE INC. | $8.99 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048576 | CMS |
| ABBVIE INC. | $19.17 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048578 | CMS |
| ABBVIE INC. | $7.72 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048580 | CMS |
| ABBVIE INC. | $8.77 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048582 | CMS |
| ABBVIE INC. | $10.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048584 | CMS |
| ABBVIE INC. | $93.68 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048586 | CMS |
| ABBVIE INC. | $7.77 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048588 | CMS |
| ABBVIE INC. | $16.54 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048590 | CMS |
| ABBVIE INC. | $10.67 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105048592 | CMS |
| Alcon Vision LLC | $22.41 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662867 | CMS |
| Alcon Vision LLC | $84.50 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662871 | CMS |
| Alcon Vision LLC | $18.26 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662863 | CMS |
| Alcon Vision LLC | $19.54 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662865 | CMS |
| Alcon Vision LLC | $126.28 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662873 | CMS |
| Alcon Vision LLC | $17.78 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662861 | CMS |
| Alcon Vision LLC | $26.53 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662869 | CMS |
| Carl Zeiss Meditec USA, Inc. | $93.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153258138 | CMS |
| Glaukos Corporation | $36.04 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985724 | CMS |
| Glaukos Corporation | $85.52 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985726 | CMS |
| Glaukos Corporation | $165.17 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151975684 | CMS |
| Glaukos Corporation | $127.16 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151975682 | CMS |
| Nova Eye, Inc. | $21.01 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149333407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.